Optimax Access has a committed team of health economists and research analysts with more than 10 years’ international experience of the healthcare industry and health outcomes sector. Our multi-disciplinary team use our experience gained in the pharmaceutical industry, academia and health services worldwide to provide its clients with a comprehensive range of services related to health outcomes research. In Optimax Access we are proud to serve our clients. We offer a wide variety of evidence review and development projects to support your products and researches in our offices in the UK, US and Canada; the following are just a few examples: Review of Evidence • Systematic reviews and interpretation of clinical and economic evidence • Structured and targeted literature reviews (e.g. burden of illness, unmet needs assessments, health technology assessment (HTA)) • Network meta-analyses and indirect treatment comparisons Economic Evidence Development • Cost-effectiveness and cost-utility models • Early economic modelling and threshold analyses • Within-trial patient-level data analysis • Cohort models and individual patient-level simulations • Global economic models or HTA agency specific models • Adapting economic models to reflect intra-country and regional differences • Budget impact models • Survival modelling and extrapolation • Health outcome studies (Health-related quality of life/utility) Strategy Planning • Methodological and strategic advice • Portfolio planning • Preparation for formal HTA scientific advice • Critical review of your HTA submission • Review, critique and development of HEOR evidence generation plans (e.g. clinical trial design and outcomes assessment/instrument selection, payer evidence planning) • Review and critique of existing economic models and HTA evidence materials